Chronic kidney disease in cancer patients: An independent predictor of cancer-specific mortality

American Journal of Nephrology

Volumn 33, Issue 2, 2011, Pages 121-130

  Na, Sun Young ^a   Sung, Ji Yoon ^a   Chang, Jae Hyun ^a   Kim, Sejoong ^a   Lee, Hyun Hee ^a   Park, Yeon Ho ^a   Chung, Wookyung ^a   Oh, Kook Hwan ^b   Jung, Ji Yong ^a  

^a Gachon University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Cancer; Chronic kidney disease; Mortality

Indexed keywords

CREATININE;

ADULT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78651405848     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323740     Document Type: Article

References (47)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
2. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
3. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92. (Pubitemid 36070938)
4. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ: Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147-1154. (Pubitemid 29330553)
5. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364-1372. (Pubitemid 36438998)
6. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615. (Pubitemid 29297538)
7. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PHM, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005; 16: 3728-3735. (Pubitemid 46211295)
8. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM: Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 2002; 25: 43-48. (Pubitemid 41070781)
9. Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Abnormal glucose tolerance and the risk of cancer death in the united states. Am J Epidemiol 2003; 157: 1092-1100. (Pubitemid 36682301)
10. Pedersen LM, Milman N: Prevalence and prognostic significance of proteinuria in patients with lung cancer. Acta Oncol 1996; 35: 691-695. (Pubitemid 26366726)
11. Satariano W: Comorbidities and cancer; in Hunter C, Johnson K, Muss H (eds): Cancer in the Elderly. New York, Dekker, 2000, pp 477-500.
12. Yung KC, Piccirillo JF: The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134: 1045-1049.
13. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P: Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103: 792-802. (Pubitemid 36113249)
14. Kleber M, Ihorst G, Deschler B, Jakob C, Liebisch P, Koch B, Sezer O, Engelhardt M: Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients. Eur J Haematol 2009; 83: 519-527.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
16. Fine J, Gray R: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-497.
17. Patel P, Henry LL, Ganti AK, Potti A: Clinical course of lung cancer in patients with chronic kidney disease. Lung Cancer 2004; 43: 297-300. (Pubitemid 38224149)
18. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161: 2524-2532. (Pubitemid 28397070)
19. Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557. (Pubitemid 32666340)
20. Gordge MP, Faint RW, Rylance PB, Ireland H, Lane DA, Neild GH: Plasma D dimer: a useful marker of fibrin breakdown in renal failure. Thromb Haemost 1989; 61: 522-525. (Pubitemid 19168168)
21. Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M: Significance of urinary fibrin/fibrinogen degradation products D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases. Clin Nephrol 1995; 44: 91-95.
22. Shlipak MG, Stehman-Breen C, Fried LF, Song X, Siscovick D, Fried LP, Psaty BM, Newman AB: The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004; 43: 861-867. (Pubitemid 38529624)
23. Landman GW, Ubink-Veltmaat LJ, Kleefstra N, Kollen BJ, Bilo HJ: Increased cancer mortality in type 2 diabetes (zodiac-3). Anticancer Res 2008; 28: 1373-1375. (Pubitemid 351578882)
24. Tseng CH, Chong CK, Tai TY: Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006. Diabetologia 2009; 52: 240-246.
25. Tseng CH, Chong CK, Tseng CP, Chan TT: Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year followup of a national cohort in Taiwan. Ann Med 2009; 41: 371-379.
26. Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H: Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. J Epidemiol 2008; 18: 197-203.
27. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of us adults. Am J Epidemiol 2004; 159: 1160-1167. (Pubitemid 38747263)
28. Zhou XH, Qiao Q, Zethelius B, Pyorala K, Soderberg S, Pajak A, Stehouwer CD, Heine RJ, Jousilahti P, Ruotolo G, Nilsson PM, Calori G, Tuomilehto J: Diabetes, prediabetes and cancer mortality. Diabetologia 2010; 53: 1867-1876.
29. Batty GD, Shipley MJ, Marmot M, Smith GD: Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall Study. Cancer Causes Control 2004; 15: 873-881. (Pubitemid 39663863)
30. Abe R, Yamagishi S: AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008; 14: 940-945. (Pubitemid 351753280)
31. Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Kaplan RC, Muzumdar R, Rohan TE, Strickler HD: The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 2009; 25: 3-12.
32. Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8: 915-928.
33. De Giorgio R, Barbara G, Cecconi A, Corinaldesi R, Mancini AM: Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med 2000; 160: 2217. (Pubitemid 30482731)
34. Nerlich AG, Hagedorn HG, Boheim M, Schleicher ED: Patients with diabetes-induced microangiopathy show a reduced frequency of carcinomas. In Vivo 1998; 12: 667-670. (Pubitemid 29012001)
35. Pedersen LM, Sorensen PG: Increased urinary albumin excretion rate in breast cancer patients. Acta Oncol 2000; 39: 145-149. (Pubitemid 30316880)
36. Sawyer N, Wadsworth J, Wijnen M, Gabriel R: Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J (Clin Res Ed) 1988; 296: 1295-1298.
37. Pedersen LM, Milman N: Microalbuminuria in patients with lung cancer. Eur J Cancer 1998; 34: 76-80. (Pubitemid 28123384)
38. Roumen RM, Wijnen MH: Proteinuria: a frequent paraneoplastic phenomenon in colorectal cancer? Eur J Cancer 1998; 34: 206-207. (Pubitemid 128717290)
39. Xie L, Wu K, Xu N, Chen D, Chen J, Lu S: Hypertension is associated with a high risk of cancer. J Hum Hypertens 1999; 13: 295-301. (Pubitemid 29248539)
40. Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E: High blood-pressure: a risk factor for cancer mortality? Lancet 1975; 1: 1051-1056.
41. Wannamethee G, Shaper AG: Blood pressure and cancer in middle-aged British men. Int J Epidemiol 1996; 25: 22-31. (Pubitemid 26060266)
42. Grove JS, Nomura A, Severson RK, Stemmermann GN: The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991; 134: 942-947.
43. Gillis GR, Hole D, MacLean DS, Hawthorne VM, Watt HD, Watkinson G: Letter: High blood pressure and cancer? Lancet 1975; 2: 612.
44. Lee SY, Kim MT, Jee SH, Im JS: Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men. J Hypertens 2002; 20: 617-622. (Pubitemid 34913703)
45. Taylor JO, Cornoni-Huntley J, Curb JD, Manton KG, Ostfeld AM, Scherr P, Wallace RB: Blood pressure and mortality risk in the elderly. Am J Epidemiol 1991; 134: 489-501.
46. Clausen J, Jensen G: Blood pressure and mortality: an epidemiological survey with 10 years' follow-up. J Hum Hypertens 1992; 6: 53-59.
47. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult us population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. (Pubitemid 36043346)